Should Systematic Infrarenal Para-aortic Dissection Be the Rule in the Pretherapeutic Staging of Primary or Recurrent Locally Advanced Cervix Cancer Patients With a Negative Preoperative Para-aortic PET Imaging?

Background Extended-field chemoradiation is the usual management of patients with locally advanced cervical cancer (LACC) and para-aortic node metastases (PA pN1). It is efficient but not without morbidity. Assessment of PA lymph node positivity by PA lymphadenectomy is the most accurate method to select the candidates for this treatment. Hence, to clarify the dissection pattern, we wanted to test the true incidence of isolated/skip node metastasis, above the level of the inferior mesenteric artery (IMA). Materials and Methods All patients with LACC and negative magnetic resonance imaging and positron emission tomography–computed tomography imaging at the PA level were offered a laparoscopic staging encompassing a diagnostic laparoscopy followed, if negative, by an extraperitoneal PA lymphadenectomy. All nodes were removed from both common iliac bifurcations up to the left renal vein. Node groups, below and above the IMA, were separately sent to the pathologist for definitive examination. Results From January 2010 to December 2013, 196 stage IB1 with pelvic pN1, IB2, to IVA LACC patients from 2 cancer centers who fulfilled the criteria were included in this institutional review board–approved study after informed consent. Thirty patients (15%) had PA pN1. Only 1 patient had positive nodes exclusively located above the IMA (3.3% of the pN1 group; 95% confidence interval, 0%–9.7%). Complications were observed in 15 (7.6%) of 196 patients. Conclusions Given the very low rate of skip metastases above the IMA and the potential additional morbidity of a systematic extended dissection, a bilateral ilioinframesenteric dissection seems to be an acceptable pattern of PA lymphadenectomy in LACC patients.

[1]  S. Kuku,et al.  Radiation-induced bowel injury: the impact of radiotherapy on survivorship after treatment for gynaecological cancers , 2013, British Journal of Cancer.

[2]  C. Haie-meder,et al.  Prospective multicenter study evaluating the survival of patients with locally advanced cervical cancer undergoing laparoscopic para-aortic lymphadenectomy before chemoradiotherapy in the era of positron emission tomography imaging. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  A. García,et al.  Location of aortic node metastases in locally advanced cervical cancer. , 2012, Gynecologic oncology.

[4]  C. Haie-meder,et al.  Analysis of morbidity and clinical implications of laparoscopic para-aortic lymphadenectomy in a continuous series of 98 patients with advanced-stage cervical cancer and negative PET-CT imaging in the para-aortic area. , 2011, The oncologist.

[5]  A. Bats,et al.  Accuracy of 18-Fluoro-2-deoxy-d-glucose Positron Emission Tomography in the Pretherapeutic Detection of Occult Para-aortic Node Involvement in Patients with a Locally Advanced Cervical Carcinoma , 2011, Annals of Surgical Oncology.

[6]  A. Gil-Moreno,et al.  Pretherapeutic Extraperitoneal Laparoscopic Staging of Bulky or Locally Advanced Cervical Cancer , 2011, Annals of Surgical Oncology.

[7]  P. Rose,et al.  Surgical versus radiographic determination of para‐aortic lymph node metastases before chemoradiation for locally advanced cervical carcinoma , 2008, Cancer.

[8]  Ziting Li,et al.  Concurrent chemotherapy and adjuvant extended field irradiation after radical surgery for cervical cancer patients with lymph node metastases , 2007, International Journal of Gynecologic Cancer.

[9]  C. Fournier,et al.  Therapeutic value of pretherapeutic extraperitoneal laparoscopic staging of locally advanced cervical carcinoma. , 2007, Gynecologic oncology.

[10]  H. Yamazaki,et al.  Frequency and characteristics of isolated para-aortic lymph node recurrence in patients with uterine cervical carcinoma in Japan: a multi-institutional study. , 2006, Gynecologic oncology.

[11]  K. Kang,et al.  Role of positron emission tomography in pretreatment lymph node staging of uterine cervical cancer: a prospective surgicopathologic correlation study. , 2005, European journal of cancer.

[12]  R. Tozzi,et al.  Introduction of transperitoneal lymphadenectomy in a gynecologic oncology center: analysis of 650 laparoscopic pelvic and/or paraaortic transperitoneal lymphadenectomies. , 2004, Gynecologic oncology.

[13]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[14]  Mitchell Morris,et al.  Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  B. Castelain,et al.  Prospective evaluation of surgical staging of advanced cervical cancer via a laparoscopic extraperitoneal approach. , 2003, Gynecologic oncology.

[16]  K. Ng,et al.  Randomized trial of surgical staging (extraperitoneal or laparoscopic) versus clinical staging in locally advanced cervical cancer. , 2003, Gynecologic oncology.

[17]  C. Köhler,et al.  Laparoscopic staging compared with imaging techniques in the staging of advanced cervical cancer. , 2002, Gynecologic oncology.

[18]  F. Amant,et al.  Laparoscopic lower para-aortic staging lymphadenectomy in stage IB2, II, and III cervical cancer , 2001, International Journal of Gynecologic Cancer.

[19]  N. Sakuragi,et al.  Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy , 1999, Cancer.

[20]  H. Meertens,et al.  The use of a transverse CT image for the estimation of the dose given to the rectum in intracavitary brachytherapy for carcinoma of the cervix. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[21]  P. Morice,et al.  Lymphatic Spread in Stage Ib and II Cervical Carcinoma: Anatomy and Surgical Implications , 1998, Obstetrics and gynecology.

[22]  N. Sakuragi,et al.  A clinical and pathologic study on para‐aortic lymph node metastasis in endometrial carcinoma , 1997, Journal of surgical oncology.

[23]  M. Piver,et al.  Pretreatment transperitoneal laparoscopic staging pelvic and paraaortic lymphadenectomy in large (> or = 5 cm) stage IB2 cervical carcinoma: report of a pilot study. , 1996, Gynecologic oncology.

[24]  T. Inoue,et al.  Prophylactic irradiation of para-aortic lymph nodes in carcinoma of the uterine cervix. A prospective randomized study. , 1995, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[25]  T. Pajak,et al.  Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20. , 1995, JAMA.

[26]  J. Schlaerth,et al.  Extraperitoneal versus transperitoneal selective paraaortic lymphadenectomy in the pretreatment surgical staging of advanced cervical carcinoma (a Gynecologic Oncology Group study) , 1989, Gynecologic oncology.

[27]  A. Gerbaulet,et al.  Is prophylactic para-aortic irradiation worthwhile in the treatment of advanced cervical carcinoma? Results of a controlled clinical trial of the EORTC radiotherapy group. , 1988, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[28]  J. Schlaerth,et al.  The influence of surgical staging on the evaluation and treatment of patients with cervical carcinoma. , 1986, Gynecologic oncology.

[29]  M. Munsell,et al.  Lymphadenectomy in locally advanced cervical cancer study (LiLACS): Phase III clinical trial comparing surgical with radiologic staging in patients with stages IB2-IVA cervical cancer. , 2014, Journal of minimally invasive gynecology.

[30]  J. Dimopoulos,et al.  Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[31]  N. Sakuragi,et al.  Distribution pattern and risk factors of pelvic and para-aortic lymph node metastasis in epithelial ovarian carcinoma. , 1998, International journal of cancer.